Qiagen NV | QIA - Assets

Stock Price
43.48
Daily Change
-0.26 -0.58%
Monthly
3.29%
Yearly
7.21%
Q1 Forecast
43.53

Qiagen NV reported $6.55B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Moderna USD 12.14B 125M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025